Qiagen Forecast, price target & analysts
Qiagen Target price 2025 - Analyst rating & recommendation
Qiagen Classifications & Recommendation:
Qiagen Price Target
| Target Price | €43.72 |
| Price | €38.27 |
| Potential | 14.27% |
| Number of Estimates | 19 |
| 19 Analysts have issued a price target Qiagen 2026 . The average Qiagen target price is €43.72. This is 14.27% higher than the current stock price. The highest price target is €50.00 30.67% , the lowest is €39.90 4.28% . | |
| A rating was issued by 23 analysts: 12 Analysts recommend Qiagen to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2026 of 14.27% . Most analysts recommend the Qiagen stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
19 Analysts have issued a sales forecast Qiagen 2025 . The average Qiagen sales estimate is €1.8b . This is 1.83% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €1.9b 3.58% , the lowest is €1.8b 4.86% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | €1.8b | 0.60% |
|---|---|---|
| 2025 | €1.8b | 0.16% |
| 2026 | €1.9b | 6.05% |
| 2027 | €2.1b | 6.89% |
| 2028 | €2.2b | 8.35% |
| 2029 | €2.5b | 10.19% |
18 Analysts have issued an Qiagen EBITDA forecast 2025. The average Qiagen EBITDA estimate is €682m . This is 2.47% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €754m 13.22% , the lowest is €620m 6.85% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | €645m | 7.27% |
|---|---|---|
| 2025 | €682m | 5.69% |
| 2026 | €736m | 7.85% |
| 2027 | €797m | 8.39% |
| 2028 | €866m | 8.64% |
| 2029 | €953m | 9.96% |
EBITDA Margin
| 2024 | 35.30% | 6.62% |
|---|---|---|
| 2025 | 37.24% | 5.51% |
| 2026 | 37.88% | 1.72% |
| 2027 | 38.41% | 1.40% |
| 2028 | 38.51% | 0.26% |
| 2029 | 38.43% | 0.21% |
12 Qiagen Analysts have issued a net profit forecast 2025. The average Qiagen net profit estimate is €394m . This is 366.64% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €449m 431.88% , the lowest is €334m 295.61% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | €75.8m | 75.86% |
|---|---|---|
| 2025 | €394m | 419.97% |
| 2026 | €437m | 10.76% |
| 2027 | €488m | 11.68% |
| 2028 | €536m | 10.04% |
| 2029 | €610m | 13.66% |
Net Margin
| 2024 | 4.14% | 76.01% |
|---|---|---|
| 2025 | 21.52% | 419.24% |
| 2026 | 22.47% | 4.41% |
| 2027 | 23.48% | 4.49% |
| 2028 | 23.85% | 1.58% |
| 2029 | 24.60% | 3.14% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
12 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen EPS is €1.82 . This is 366.67% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.07 430.77% , the lowest is €1.54 294.87% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | €0.35 | 75.86% |
|---|---|---|
| 2025 | €1.82 | 420.00% |
| 2026 | €2.02 | 10.99% |
| 2027 | €2.25 | 11.39% |
| 2028 | €2.48 | 10.22% |
| 2029 | €2.82 | 13.71% |
P/E ratio
| Current | 97.71 | 231.22% |
|---|---|---|
| 2025 | 21.03 | 78.48% |
| 2026 | 18.98 | 9.75% |
| 2027 | 17.00 | 10.43% |
| 2028 | 15.45 | 9.12% |
| 2029 | 13.59 | 12.04% |
Based on analysts' sales estimates for 2025, the Qiagen stock is valued at an EV/Sales of 4.74 and an P/S ratio of 4.51 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.65 | 13.41% |
|---|---|---|
| 2025 | 4.74 | 1.92% |
| 2026 | 4.47 | 5.70% |
| 2027 | 4.18 | 6.45% |
| 2028 | 3.86 | 7.70% |
| 2029 | 3.50 | 9.25% |
P/S ratio
| Current | 4.43 | 12.39% |
|---|---|---|
| 2025 | 4.51 | 1.86% |
| 2026 | 4.26 | 5.71% |
| 2027 | 3.98 | 6.45% |
| 2028 | 3.68 | 7.70% |
| 2029 | 3.34 | 9.25% |
Current Qiagen Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Neutral
➜
Neutral
|
Unchanged | Apr 21 2025 |
| Redburn Atlantic |
Buy
➜
Neutral
|
Downgrade | Apr 04 2025 |
| Baird |
Outperform
➜
Neutral
|
Downgrade | Feb 19 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Feb 07 2025 |
| Morgan Stanley |
Overweight
➜
Equal-Weight
|
Downgrade | Jan 06 2025 |
| HSBC |
Buy
➜
Hold
|
Downgrade | Oct 17 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Apr 21 2025 |
|
Downgrade
Redburn Atlantic:
Buy
➜
Neutral
|
Apr 04 2025 |
|
Downgrade
Baird:
Outperform
➜
Neutral
|
Feb 19 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Feb 07 2025 |
|
Downgrade
Morgan Stanley:
Overweight
➜
Equal-Weight
|
Jan 06 2025 |
|
Downgrade
HSBC:
Buy
➜
Hold
|
Oct 17 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
